Business · 23/05/1996

FDA Approves New Animal Drug for Reversing Sedation and Analgesia in Horses

The US Food and Drug Administration (FDA) has amended its regulations to approve a new animal drug application filed by Lloyd, Inc. for the use of Tolazine TM Injection in horses to reverse the effects of sedation and analgesia caused by xylazine, effective May 23, 1996.